Table 3 Univariate analysis of all patients (n = 146) for primary and secondary endpoint
From: Left ventricular long axis strain: a new prognosticator in non-ischemic dilated cardiomyopathy?
Variable | Primary endpoint | Secondary endpoint | ||||
|---|---|---|---|---|---|---|
HR | 95%CI | p-value | HR | 95%CI | p-value | |
Gender | 0.91 | 0.34–2.43 | 0.85 | 0.77 | 0.35–1.70 | 0.52 |
Age (yrs) | 1.02 | 0.99–1.05 | 0.15 | 1.03 | 1.00–1.05 | 0.04 |
NYHA class | 1.13 | 0.60–2.11 | 0.70 | 1.32 | 0.78–2.26 | 0.31 |
LVEF (%) | 0.90 | 0.86–0.94 | <0.0001 | 0.92 | 0.89–0.95 | <0.0001 |
LVEDV/BSA (ml/m2) | 1.02 | 1.01–1.02 | <0.0001 | 1.01 | 1.01–1.02 | <0.0001 |
LGE present | 3.43 | 1.42–8.27 | 0.006 | 2.00 | 1.01–3.95 | 0.048 |
LVGFI (%) | 0.86 | 0.81–0.91 | <0.0001 | 0.89 | 0.85–0.93 | <0.0001 |
LAS (%) | 1.46 | 1.25–1.71 | <0.0001 | 1.41 | 1.23–1.60 | <0.0001 |